Undetected Iatrogenic Drug-Induced Complications in a Hemodialyzed Anuric Patient: A Case Report and Review of the Literature

Anuric hemodialyzed end-stage renal disease patients are prone to multiple complications and comorbidities and are therefore often treated with various medications. Adverse drug reactions and risk factors leading to them can be difficult to discern in such polymedicated patients. Most problems regar...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in nephrology and dialysis 2022-10, Vol.12 (3), p.212-218
Main Authors: Cubilier, Edouard, Salaouatchi, Mohamed Tayeb, Taghavi, Maxime, Kaysi, Saleh, Nortier, Joëlle, Mesquita, Maria do Carmo Filomena
Format: Article
Language:English
Subjects:
Anemia
Antacids
Antibiotics
anuric patients
Case reports
Catheters
Convulsions & seizures
drug-induced complications
Gastroesophageal reflux
Hemodialysis
Hospitalization
Hydrocephalus
Hypertension
Metabolism
Patients
Phosphorus
Radiography
Single Case
Sodium
Tomography
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anuric hemodialyzed end-stage renal disease patients are prone to multiple complications and comorbidities and are therefore often treated with various medications. Adverse drug reactions and risk factors leading to them can be difficult to discern in such polymedicated patients. Most problems regarding low phosphate levels are frequently underdiagnosed in clinical practice and sometimes overlooked in these regularly hyperphosphatemic patients. Hemodialysis vascular accesses are frequently subject to infections and therefore require adapted antibiotic treatments. We report a case of an occult severe multifactorial hypophosphatemia in an anuric hemodialyzed patient with multiple comorbidities who required two hospitalizations for encephalopathy, seizures, and cardiac failure. Retrospective analysis of the medical record revealed several underlying causes of hypophosphatemia, as well as undetected risk factors for adverse drug reactions related to cephalosporins. A global approach to these concerns in routine clinical practice would raise awareness of often disregarded issues related to hypophosphatemia and drug prescription in these patients.
ISSN:2296-9705
2296-9705
DOI:10.1159/000527197